An overview of non-Hodgkin’s lymphoma
CPD Previous     Next

An overview of non-Hodgkin’s lymphoma

Helen King Education and practice development nurse, Trinity Hospice, Clapham, London
Rebecca Myatt Nurse case manager, Thoracic surgery, Guy’s Hospital, London

Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoproliferative malignancies with differing patterns of behaviour and responses to treatment. Chemotherapy, radiotherapy and stem cell transplantation are the main treatment modalities, but targeted therapies such as monoclonal antibodies are improving survival. The complex nature of the disease, and different treatment pathways, mean that nurses working in this area need in-depth knowledge to provide patient education, continuity of care and advice on current treatment options, as well as to ensure an optimal patient journey.

Correspondence hking@trinityhospice.com

Cancer Nursing Practice. 13, 1,31-38. doi: 10.7748/cnp2014.02.13.1.31.e1042

Received: 21 October 2013

Accepted: 24 December 2013

Published in print: 11 February 2014

Peer review

This article has been subject to double blind peer review

Conflict Of Interest

None declared